ODYY supply chain intelligence for Odyssey Health, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Odyssey Health, Inc. (ODYY) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| NEURX-HEALTH-INC | NEURX-HEALTH-INC | 92% | On May 6, 2026, Odyssey Health, Inc., a Nevada corporation (the "Company" "Odyssey"), received formal written notice from NeuRX Health, Inc. ("NeuRX"), a Wyoming corporation, advising that NeuRX is i… |
| PREVACUS-INC | PREVACUS-INC | 92% | On January 7, 2021, we entered into an Asset Purchase Agreement (the “APA”) with Prevacus, Inc. ("Prevacus"), pursuant to which we purchased the assets and all of the rights, interests and intellectu… |
| MAST-HILL-FUND-L-P | MAST-HILL-FUND-L-P | 90% | we received net proceeds of $190,500 pursuant to a Securities Purchase Agreement with Mast Hill. |
| MAST-HILL | MAST-HILL | 85% | Mast Hill converted $ 80,618 of accrued interest and $ 1,750 in fees for a total of $ 82,368 into 1,144,000 shares of our common stock at a conversion |
| FIVE-VENDORS | FIVE-VENDORS | 80% | During the quarter ended April 30, 2026, a total of $ 85,369 of accounts payable was forgiven by a total of five vendors |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| DAVION-HEALTHCARE-PLC | DAVION-HEALTHCARE-PLC | 90% | Specifically, NeuRX failed to obtain Davion's required approval prior to sublicensing the BreastCheck product to Odyssey. |
| MAST-HILL-FUND-L-P | MAST-HILL-FUND-L-P | 90% | On December 31, 2025, we entered into the second tranche of the November 13, 2025, Securities Purchase Agreement with Mast Hill and received net proceeds of $437,500. |
| PETER-D-ARRUDA | PETER-D-ARRUDA | 80% | On October 3, 2025, we entered into a $100,000 promissory note with Peter D’Arruda, a non-affiliated accredited investor. |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| ODYY-DEBT-11488 | Warrants outstanding: 0.35 | 90% | xbrl warrant detail from xbrl 2025-07-31. |
| ODYY-DEBT | Debt stack $1.2M | 90% | Market cache reports total debt of $1.2M. |
| ODYY-DEBT-11489 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2024-07-31. |